Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Molecular Cancer |
| Online Access: | https://doi.org/10.1186/s12943-025-02251-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571936301907968 |
|---|---|
| author | Claire Corcoran Sweta Rani Susan Breslin Martina Gogarty Irene M Ghobrial John Crown Lorraine O’Driscoll |
| author_facet | Claire Corcoran Sweta Rani Susan Breslin Martina Gogarty Irene M Ghobrial John Crown Lorraine O’Driscoll |
| author_sort | Claire Corcoran |
| collection | DOAJ |
| format | Article |
| id | doaj-art-79e2ccb78cad4c06ab981d31b68fe30e |
| institution | Kabale University |
| issn | 1476-4598 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Molecular Cancer |
| spelling | doaj-art-79e2ccb78cad4c06ab981d31b68fe30e2025-02-02T12:11:32ZengBMCMolecular Cancer1476-45982025-01-012411310.1186/s12943-025-02251-8Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancerClaire Corcoran0Sweta Rani1Susan Breslin2Martina Gogarty3Irene M Ghobrial4John Crown5Lorraine O’Driscoll6School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College DublinSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College DublinSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College DublinSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College DublinDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical SchoolDepartment of Oncology, St. Vincent’s University HospitalSchool of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublinhttps://doi.org/10.1186/s12943-025-02251-8 |
| spellingShingle | Claire Corcoran Sweta Rani Susan Breslin Martina Gogarty Irene M Ghobrial John Crown Lorraine O’Driscoll Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer Molecular Cancer |
| title | Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer |
| title_full | Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer |
| title_fullStr | Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer |
| title_full_unstemmed | Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer |
| title_short | Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer |
| title_sort | correction mir 630 targets igf1r to regulate response to her targeting drugs and overall cancer cell progression in her2 over expressing breast cancer |
| url | https://doi.org/10.1186/s12943-025-02251-8 |
| work_keys_str_mv | AT clairecorcoran correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer AT swetarani correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer AT susanbreslin correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer AT martinagogarty correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer AT irenemghobrial correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer AT johncrown correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer AT lorraineodriscoll correctionmir630targetsigf1rtoregulateresponsetohertargetingdrugsandoverallcancercellprogressioninher2overexpressingbreastcancer |